FEATURE SELECTION USING EXTRA TREES CLASSIFIER FOR PARKINSON’S DISEASE CLASSIFICATION
JOURNAL OF MECHANICS OF CONTINUA AND MATHEMATICAL SCIENCES,
Journal Year:
2024,
Volume and Issue:
spl11(1)
Published: May 24, 2024
Parkinson's
disease
(PD)
is
chronic,
permanent,
and
life-threatening.
Neurologically
protective
treatments
for
PD
rely
on
early
detection.
Recent
studies
have
demonstrated
that
clinical
data,
cerebrospinal
Fluid
(CSF)
based
proteomes,
gene
mutations
are
important
biomarkers
accurate
detection
of
PD.
This
study
aims
to
investigate
the
heterogeneous
data
comprised
CSF-based
proteomic
analysis
as
well
mutation
information
genes,
Glucose
Beta
Acid
(GBA),
leucine-rich
kinase
(LRRK2)
classify
controls
into
PD-affected
Healthy
Control
(HC).
The
dataset
contains
1103
(569
affected
534
HC).
Automated
Machine
Learning
(AutoML)
framework
using
PyCaret
utilized.
has
proposed
an
Extra
Tree
Classifier
(ETC)
a
feature
selection
mechanism
select
features
significantly
affect
classification.
Selected
further
used
train
Random
Forest
(RF),
Logistic
Regression
(LR),
Decision
(DT)
classifiers.
Accuracy,
sensitivity,
specificity,
area
under
receiver
operating
characteristic
curve
(AUC-ROC),
confusion
matrix
evaluate
performance
RF
depicted
best
in
terms
accuracy
value
96.12%,
sensitivity
95.59%,
specificity
95.34%
while
LR
shown
highest
AUC
98.33.
made
number
correct
predictions
316
out
331.
Language: Английский
Enhanced Parkinson’s Disease Diagnosis via MRI Analysis: Integrating Deep Features From DenseNet201 With Neural Network Techniques
Applied Computational Intelligence and Soft Computing,
Journal Year:
2024,
Volume and Issue:
2024(1)
Published: Jan. 1, 2024
Parkinson’s
disease
(PD)
is
a
neurodegenerative
disorder
that
affects
millions
of
people
worldwide,
necessitating
accurate
and
timely
diagnostic
methods
for
effective
management.
This
study
proposes
novel
approach
PD
detection
using
deep
features
extracted
from
magnetic
resonance
imaging
(MRI)
scans,
employing
pattern
recognition
neural
network
architecture
based
on
DenseNet201.
The
developed
model
demonstrated
exceptional
performance,
achieving
validation
test
accuracies
99.4%
99.2%,
respectively,
indicating
its
robustness
efficacy
in
distinguishing
between
patients
with
healthy
individuals.
Furthermore,
the
achieved
precision
99.5%,
recall
99.3%,
an
F1
score
99.4%.
For
set,
accuracy
was
at
99.1%,
99.2%.
rapid
convergence
during
training
further
underscores
efficiency
learning
discriminative
MRI
images.
These
findings
underscore
promising
role
techniques,
particularly
convolutional
networks
(CNNs),
medical
image
analysis
diagnosis.
proposed
holds
significant
potential
assisting
clinicians
early
diagnosis
personalized
treatment
planning,
ultimately
improving
patient
outcomes
quality
life.
Language: Английский
Exploring the Potential Imaging Biomarkers for Parkinson’s Disease Using Machine Learning Approach
Illia Mushta,
No information about this author
Sulev Kõks,
No information about this author
Антон Попов
No information about this author
et al.
Bioengineering,
Journal Year:
2024,
Volume and Issue:
12(1), P. 11 - 11
Published: Dec. 27, 2024
Parkinson's
disease
(PD)
is
a
neurodegenerative
disorder
characterized
by
motor
and
neuropsychiatric
symptoms
resulting
from
the
loss
of
dopamine-producing
neurons
in
substantia
nigra
pars
compacta
(SNc).
Dopamine
transporter
scan
(DATSCAN),
based
on
single-photon
emission
computed
tomography
(SPECT),
commonly
used
to
evaluate
dopaminergic
striatum.
This
study
aims
identify
biomarker
DATSCAN
images
develop
machine
learning
(ML)
algorithm
for
PD
diagnosis.
Using
13
DATSCAN-derived
parameters
patient
handedness
1309
individuals
Progression
Markers
Initiative
(PPMI)
database,
we
trained
an
AdaBoost
classifier,
achieving
accuracy
98.88%
area
under
receiver
operating
characteristic
(ROC)
curve
99.81%.
To
ensure
interpretability,
applied
local
interpretable
model-agnostic
explainer
(LIME),
identifying
contralateral
putamen
SBR
as
most
predictive
feature
distinguishing
healthy
controls.
By
focusing
single
biomarker,
our
approach
simplifies
diagnosis,
integrates
seamlessly
into
clinical
workflows,
provides
interpretable,
actionable
insights.
Although
has
limitations
detecting
early-stage
PD,
demonstrates
potential
ML
enhance
diagnostic
precision,
contributing
improved
decision-making
outcomes.
Language: Английский